PMID- 25224628 OWN - NLM STAT- MEDLINE DCOM- 20150519 LR - 20220330 IS - 1881-7823 (Electronic) IS - 1881-7815 (Linking) VI - 8 IP - 4 DP - 2014 Aug TI - Ferulic acid combined with astragaloside IV protects against vascular endothelial dysfunction in diabetic rats. PG - 217-26 AB - Dysfunction of the endothelium is regarded as an important factor in the pathogenesis of vascular disease in diabetes mellitus (DM). Unfortunately, prevention of the progression of vascular complications of DM remains pessimistic. Ferulic acid and astragaloside IV, isolated from traditional Chinese medicine Angelica sinensis and Radix astragali respectively, exhibit potential cardio-protective and anti-hyperglycemic properties. In the present study, we investigated the protective effects and underlying mechanism of ferulic acid and astragaloside IV against vascular endothelial dysfunction in diabetic rats. After the diabetic rat model was established using streptozotocin, sixty rats were divided into 6 groups (control, model, ferulic acid, astragaloside IV, ferulic acid + astragaloside IV, and metformin) and treated for 10 weeks. Blood samples were collected to measure levels of hemoglobin A1c (HbAlc), triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), low density lipoproteins (Ox-LDL), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and creatinine (Cr), nitric oxide (NO) and endothelial nitric oxide synthase (eNOS), and abdominal aorta tissue samples were collected for observing histological morphology changes of endothelium and detecting gene and protein expression of nuclear factor-kappaB (NF-kappaB) P65, monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor alpha (TNF-alpha). We found that ferulic acid combined with astragaloside IV was capable of improving the structure of the aortic endothelium wall, attenuating the increase of HbAlc, TG, TC, LDL-C and Ox-LDL, promoting the release of NO and eNOS, and inhibiting over-activation of MCP-1, TNF-alpha, and NF-kappaB P65, without damage to liver and kidney function. In conclusion, ferulic acid combined with astragaloside IV exhibited significant protective effects against vascular endothelial dysfunction in diabetic rats through the NF-kappaB pathway involving decrease of Ox-LDL, increase of NO and eNOS, and activation of NF-kappaB P65, MCP-1 and TNF-alpha. FAU - Yin, Yonghui AU - Yin Y AD - Department of Endocrinology, the First Affiliated Hospital of Shandong University of Traditional Chinese Medicine. FAU - Qi, Fanghua AU - Qi F FAU - Song, Zhenhua AU - Song Z FAU - Zhang, Bo AU - Zhang B FAU - Teng, Jialin AU - Teng J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Japan TA - Biosci Trends JT - Bioscience trends JID - 101502754 RN - 0 (Coumaric Acids) RN - 0 (Hypoglycemic Agents) RN - 0 (Saponins) RN - 0 (Triterpenes) RN - 3A592W8XKE (astragaloside A) RN - AVM951ZWST (ferulic acid) SB - IM MH - Animals MH - Aorta, Abdominal/drug effects/metabolism/pathology MH - Coumaric Acids/administration & dosage/chemistry/*therapeutic use MH - Diabetes Mellitus, Experimental/blood/complications/*drug therapy/metabolism MH - Diabetic Angiopathies/blood/etiology/metabolism/*prevention & control MH - Drug Therapy, Combination MH - Endothelium, Vascular/*drug effects/metabolism/pathology MH - Hypoglycemic Agents/administration & dosage/chemistry/*therapeutic use MH - Male MH - Molecular Structure MH - Rats, Wistar MH - Saponins/administration & dosage/chemistry/*therapeutic use MH - Triterpenes/administration & dosage/chemistry/*therapeutic use EDAT- 2014/09/17 06:00 MHDA- 2015/05/20 06:00 CRDT- 2014/09/17 06:00 PHST- 2014/09/17 06:00 [entrez] PHST- 2014/09/17 06:00 [pubmed] PHST- 2015/05/20 06:00 [medline] AID - DN/JST.JSTAGE/bst/2014.01081 [pii] AID - 10.5582/bst.2014.01081 [doi] PST - ppublish SO - Biosci Trends. 2014 Aug;8(4):217-26. doi: 10.5582/bst.2014.01081.